Both in Pharmaceuticals
Cronos Group Inc. Common Share vs Bicara Therapeutics
Over the past year CRON returned +13.8% and BCAX returned +33.8%; their daily moves had a correlation of 0.11.
CRON +13.8% BCAX +33.8%Growth of $1, one year, split-adjusted
| Metric | CRON | BCAX |
|---|---|---|
| Price | $3.38 | $18.56 |
| Market cap | $1.25B | $1.23B |
| Today | −0.88% | −1.28% |
| 1 month | 0.0% | −20.8% |
| 6 months | +38.5% | −2.5% |
| Year to date | +28.5% | +10.3% |
| 1 year | +28.5% | +58.5% |
| Revenue growth (YoY) | +59.5% | — |
| Gross margin | 65.8% | — |
| Net margin | 45.4% | — |
| P/E (TTM) | 17.8× | — |
| Price / sales | 4.8× | — |
| Net cash | $797.0M | $497.3M |
| Dividend yield | — | — |
| Volatility (60d) | 37.4% | 56.5% |
| Short % of float | 1.7% | 22.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).